Finasteride-loaded biodegradable nanoparticles: Near-infrared quantification of plasma and prostate levels

Abstract

Finasteride is an orally active testosterone 5-alpha-reductase inhibitor that is used for the treatment of benign prostatic hyperplasia as a surgical alternative. The aim of this work was to improve finasteride levels in plasma and prostate through the formulation of biodegradable finasteride nanoparticles and to quantify finasteride levels using near-infrared application. Finasteride nanoparticles were prepared by emulsion solvent evaporation method utilizing the biodegradable polymers poly(lactic-co-glycolic acid) and poly-ϵ-caprolactone. The prepared nanoparticles were characterized by particle size, zeta potential, and encapsulation efficiency. The selected finasteride-biodegradable formula was examined in vivo, and both plasma and prostate levels of finasteride were quantified utilizing near-infrared technique. Results revealed that the prepared finasteride nanoparticles size range was from 231 ± 78 to 956 ± 224 nm with finasteride–poly-ϵ-caprolactone nanoparticles showing larger particle sizes compared with finasteride–poly(lactic-co-glycolic acid) nanoparticles. The encapsulation efficiency ranged from 68.89% ± 2.99% to 99.15% ± 4.32%. The selected formula of finasteride nanoparticles showed improved levels of finasteride in both plasma and prostate of the investigated rats. The realization of sustained release of biodegradable finasteride nanoparticles for possible oral or parenteral application could improve the activity of the drug for sustaining release time with lower dosing recurrence that improves patient compliance.

Keywords

poly-ϵ-caprolactone prostatitis near-infrared dihydrotestosterone

Get full access to this article

View all access options for this article.

References

Amaral

Varela

Correia-Da-Silva

et al . New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line. Biochimie 2013; 95: 2097–2106.

Amory

JK.

Oral testosterone in oil: pharmacokinetic effects of 5 reduction by finasteride or dutasteride and food intake in men. J Androl 2006; 27: 72–78.

Berkland

Kim

Pack

DW.

Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions. J Control Release 2001; 73: 59–74.

Bhatt

Shah

Influence of additives on fabrication and release from protein loaded microparticles. Iran J Pharm Sci 2012; 8: 171–180.

Brazel

Peppas

NA.

Modeling of drug release from swellable polymers. Eur J Pharm Biopharm 2000; 49: 47–58.

Chorny

Fishbein

Danenberg

et al . Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics. J Control Release 2002; 83: 389–400.

Dong

Feng

SS.

Poly(D,L-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005; 26: 6068–6076.

Franssen

Stenekes

RJH

Hennink

WE.

Controlled release of a model protein from enzymatically degrading dextran microspheres. J Control Release 1999; 59: 219–228.

Carlin

Christofalo

Arison

et al . Disposition and metabolism of finasteride in dogs. Drug Metab Dispos 1997; 25(1): 100–109.

10.

Fwu

Eggers

Kaplan

et al . Long-term effects of doxazosin, finasteride and combination therapy on quality of life in men with benign prostatic hyperplasia. J Urol 2013; 190: 187–193.

11.

Israel

MO.

Effects of topical and dietary use of shea butter on animals. Am J Life Sci 2014; 2: 303–307.

12.

Burgess

. Valid analytical methods and procedures. R Soc Chem Adv 2000: 60–66.

13.

Ahmed

Kurakula

Banjar

et al . Quality by design coupled with near infrared in formulation of transdermal glimepiride liposomal films. J Pharm Sci 2015; 1: 2062–2075.

14.

Mohamed

Ahmed

OAA

Amin

et al . In-vivo evaluation of clindamycin release from glyceryl monooleate-alginate microspheres by NIR spectroscopy. Int J Pharm 2015; 494: 127–135.

15.

Schindler

Watkins

Vonach

et al . Automated multivariate calibration in sequential injection-Fourier transform infrared spectroscopy for sugar analysis. Anal Chem 1998; 15: 226–231.

16.

Reich

Near-infrared spectroscopy and imaging: basic principles and pharmaceutical applications. Adv Drug Deliv Rev 2005; 57: 1109–1143.

17.

Ahmed

Hosny

Al-Sawahli

et al . Optimization of caseinate-coated simvastatin-zein nanoparticles: improved bioavailability and modified release characteristics. Drug Des Devel Ther 2015; 9: 655–662.

18.

Liu

Sun

Wang

et al . Microspheres of corn protein, zein, for an ivermectin drug delivery system. Biomaterials 2005; 26: 109–115.

19.

Mainardes

Evangelista

RC.

PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm 2005; 290: 137–144.

20.

Mandal

Mittal

Balabathula

et al . Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer. Eur J Pharm Sci 2016; 81: 162–171.

21.

Sakai

Sekita

Tanaka

et al . Preparation and properties of nanosized biodegradable polymer capsules. J Oleo Sci 2011; 60: 569–573.

22.

Pisco

Rio Tinto

Campos Pinheiro

et al . Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up. Eur Radiol 2013; 23: 2561–2572.

23.

Azizi

Namazi

Haririan

et al . Release profile and stability evaluation of optimized chitosan/alginate nanoparticles as EGFR antisense vector. Int J Nanomedicine 2010; 5: 455–461.

24.

Quintanar-Guerrero

Ganem-Quintanar

Allémann

et al . Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique. J Microencapsul 1998; 15: 107–119.

25.

Rao

Zheng

Zhang

et al . In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers. AAPS PharmSciTech 2008; 9: 860–865.

26.

Segall

Vitale

Perez

et al . A stability-indicating HPLC method to determine finasteride in a tablet formulation. J Liq Chromatogr R T 2002; 25: 3167–3176.

27.

Surolia

Pachauri

Ghosh

PC.

Preparation and characterization of monensin loaded PLGA nanoparticles: in vitro anti-malarial activity against Plasmodium falciparum. J Biomed Nanotechnol 2012; 8: 172–181.

28.

Tabbakhian

Tavakoli

Jaafari

et al . Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int J Pharm 2006; 323: 1–10.

29.

Thigpen

Silver

Guileyardo

et al . Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression. J Clin Invest 1993; 92: 903–910.

30.

Trost

Saitz

Hellstrom

WJG

. Side effects of 5-Alpha reductase inhibitors: a comprehensive review. Sex Med Rev 2013; 1: 24–41.

31.

Wang

Fan

D-D

Jin

et al . Differential expression of 5-alpha reductase isozymes in the prostate and its clinical implications. Asian J Androl 2014; 16: 274–279.

32.

Cao

K-H

Teoh

S-H.

Scaffold design and in vitro study of osteochondral coculture in a three-dimensional porous polycaprolactone scaffold fabricated by fused deposition modeling. Tissue Eng 2003; Suppl. 1: 103–112.

33.

Williams

Adewunmi

Rachel

et al . Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials 2005; 26: 4817–4827.

34.

Nava-Arzaluz

Piñón-Segundo

Ganem-Rondero

et al . Single emulsion-solvent evaporation technique and modifications for the preparation of pharmaceutical polymeric nanoparticles. Recent Pat Drug Deliv Formul 2012; 1(6): 209–223.

35.

Sandri

Bonferoni

Ferrari

et al . The role of particle size in drug release and absorption. Particul Prod 2014; 19: 323–341.

36.

Pereira

Araujo

Granja

et al . Targeting membrane transporters and receptors as a mean to optimize orally delivered biotechnological based drugs through nanoparticle delivery systems. Curr Pharm Biotechnol 2014; 15(7): 650–658.

37.

Fahmy

UA.

Nanoethosomal transdermal delivery of vardenafil for treatment of erectile dysfunction: optimization, characterization, and in vivo evaluation. Drug Des Devel Ther 2015; 9: 6129–6137.

38.

Kaur

Singh

Yadav

et al . Potential of nanomaterials as movers and packers for drug molecules. Sol St Phen 2014; 222: 159–178.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.17 MB